Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81
Warning: fopen(upload/ip_log/ip_log_2024-11.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83
Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 Serological diagnosis of human sparganosis by means of micro-ELISA
Serological diagnosis of human sparganosis by means of micro-ELISA
Hyuck Kim,Suk-Il Kim and Seung-Yull Cho
Department of Parasitology, College of Medicine, Chung-Ang University, Seoul 151, Korea.
Abstract
Seven cases of surgically proven sparganosis were serologically tested by means of micro ELISA for their specific IgG antibody levels. For that purpose, crude saline extract of spargana from snake, Natrix tigrina lateralis was prepared and used as antigen. The sparganosis sera were also tested with Paragonimus and Cysticercus antigens to observe the cross reactivity. A total of 71 sera from normal control, ectopic and pulmonary paragonimiasis, clonorchiasis, cysticercosis and Taenia saginata cases were also included.
Except for one case of old calcified infection, all of 6 human sparganosis showed higher serum levels of specific IgG antibody when the differential point of positive reaction was set at the absorbance value of 0.25 (the sensitivity being 85.7%). In control and other helminthic infections, all except 3 cases of T. saginata infection showed negative reaction to sparganum antigen (the specificity being 95.7%).
None of sparganosis cases showed cross reactivity to Paragonimus and Cysticercus antigens. Undiluted cerebrospinal fluid also showed high levels of antibody when central nervous system was invaded.
The serologic diagnosis by means of micro-ELISA could be a useful tool in epidemiological study of human sparganosis in susceptible population, as well as in individual diagnosis.
Figures
Fig. 1 Results of micro-ELISA to sparganum antigen in different groups as shown by individual absorbance, Group I: Sparganosis, Group II: Cysticercosis, Group III: Paragonimiasis, Group IV: Clonorchiasis, Group V: Taenia saginata infection, Group VI: Normal control
Tables
Table 1 Antibody levels in cerebrospinal fluid of two CNS sparganosis cases against 3 different helminthic antigens
References
1.
Byun DG, et al. Korean J Dermatol 1982;20(3):501–505.
2.
Chi JG, Chi HS, Lee SH. Histopathologic Study On Human Sparganosis. Korean J Parasitol 1980;18(1):15–23.
3.
Cho SY, et al. J Korean Med Assoc 1974;17(5):367–371.
4.
Cho SY, Bae JH, Seo BS. Some Aspects Of Human Sparganosis In Korea. Korean J Parasitol 1975;13(1):60–77.
5.
Cho SY, Hong ST, Rho YH, Choi SY, Han YC. Application of micro-ELISA in serodiagnosis of Human paragonimiasis. Korean J Parasitol 1981;19(2):151–156.
6.
Cho SY, et al. Chuns-Ang J Med 1982;7(4):321–333.
7.
Lee SK, et al. J Pusan Med College 1967;7(2):87–92.
8.
McLaren M, Draper CC, Roberts JM, Minter-Goedbloed E, Ligthart GS, Teesdale CH, Amin MA, Omer AH, Bartlett A, Voller A. Studies on the enzyme linked immunosorbent assay (ELISA) test for Schistosoma mansoni infections. Ann Trop Med Parasitol 1978;72(3):243–253.
9.
Okabe H, et al. Kurume J Med 1957;20:907–913.
10.
Park CK, et al. J Korean Neurosurg Soc 1983;12(4):739–743.
11.
Torres JR, Noya OO, Noya BA, Mouliniere R, Martinez E. Treatment of proliferative sparganosis with mebendazole and praziquantel. Trans R Soc Trop Med Hyg 1981;75(6):846–847.